On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdaySep 28, 2022 9:00 am

Odyssey Health, Inc.’s (ODYY) Brain-Related Drug Development Programs Taking Aim at Conditions with High Unmet Clinical Needs

Odyssey is a medical company focused on products that offer clinical advantages to unmet clinical needs Its brain-related drug development programs are currently focused on treatments for concussion and the Niemann Pick Type-C (“NPC”) disease, both of which do not currently have approved treatments The company is also developing medical devices such as the intranasal drug delivery device, CardioMap, and Save-A-Life Scientists and specialists describe concussion, which is also referred to as mild traumatic brain injury (“mTBI”), as a spectrum. On the one hand, some concussed patients fully recover and do not require medical intervention or attention; on the other,…

Continue Reading

TuesdaySep 27, 2022 11:15 am

Coyuchi Inc. Is ‘One to Watch’

All Coyuchi products begin with 100% organic fibers and a traceable supply chain Coyuchi achieved 26% sales revenue growth in calendar 2021 over 2020 Coyuchi is profitable and growing; for the year ended December 31, 2021, the company had net income of $1.4 million on sales of $33.3 million Coyuchi has filed an SEC Regulation A Offering Statement with the intent to offer shares for sale The overall U.S. market for home textiles is currently worth $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025…

Continue Reading

TuesdaySep 27, 2022 10:30 am

Freight Technologies Inc.’s (NASDAQ: FRGT) CFO, Paul Freudenthaler, and President Mike Flinker, Present Company’s Latest Corporate Updates at the H.C. Wainwright 24th Annual Global Investment Conference

Fr8Tech’s August 15, 2022, corporate update formed the backbone for its presentation at the H.C. Wainwright 24th Annual Global Investment Conference held from September 12-14, 2022 The company was represented by Paul Freudenthaler and Mike Flinker, who also talked about the company’s role in revolutionizing cross-border shipping, and the role of AI and machine learning in solving current logistical problems in the industry within the NAFTA region Fr8Tech remains committed to exploring new ways to create more value for its clients and streamline the region’s cross-border shipping process, and leveraging technology Javier Selgas, the company’s CEO, maintains that Fr8Tech anticipates…

Continue Reading

TuesdaySep 27, 2022 9:45 am

Electric Vehicles: The Greatest Comeback of All Time

EVs have been around for more than a century and once commanded almost half the U.S. auto market; a rise to the top is in the works today Hillcrest Energy is pioneering work in next-generation power inverters that are instrumental in EV operations and performance Hillcrest’s inverters are a leap forward in EV tech, reducing the overall size, weight, and cost while improving power quality, material elimination of switching losses, and a reduction in electromagnetic compatibility issues The history of electric vehicles (“EVs”) in the United States dates to 1891, when William Morrison built a six-passenger wagon widely recognized as…

Continue Reading

TuesdaySep 27, 2022 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Providing Quantum Applications for Life Sciences Industry With Potential to Transform Discovery, Production, and More

Quantum computing provides companies with promising new technologies that have the potential to streamline the drug development and patient trial processes, potentially finding greater efficiencies than classical computing systems D-Wave has demonstrated that annealing quantum computers could play a transformational role in the life sciences industry, as illustrated by the company’s work with Menten AI and its achievements in protein design The life sciences industry is centered around researching, developing, and manufacturing products to improve the lives of humans – including drug discovery. Drug discovery is a high-risk, high-reward field that helps to deliver life-changing clinical benefits to millions of…

Continue Reading

MondaySep 26, 2022 12:45 pm

Crypto Fest 2022 Gears Up for Networking and Entertainment for the Crypto-Defi-NFT-Web3 Community

The 4th edition of the Crypto Fest 2022 is being held on September 30, 2022, as a hybrid event in Cape Town, South Africa, and via live stream. Enthusiasts, businesses, and traders all over the world looking forward to the event can participate virtually. The Crypto Fest, in collaboration with the SA Innovation Summit, the largest startup event in Africa, is a part of the Week of Innovation taking place in Cape Town over 3 days, the 27-29 September 2022.  The abode of heritage sites, beautiful beaches, and a plethora of scenic places and natural reserves, South Africa is the perfect…

Continue Reading

MondaySep 26, 2022 12:00 pm

The 420 Expo, NJ’s First BYOC Public Event, Sparks High Attendance, Open Conversations & Awesome Vibe

Approximately 17,000 People Came Through the Doors of the Inaugural Event in Edison, NJ The 420 Expo, New Jersey’s first-ever BYOC Consumer Cannabis Convention, was an unmitigated success for the cannabis community, exceeding all expectations. Approximately 17,000 people aged 21+ attended the historic three-day event, from September 16-18, 2022, at the NJ Convention & Expo Center in Edison, NJ. Hosted by the legendary Tommy Chong and presented by Wakit Grinders, the 420 Expo brought together experienced cannabis users, the “canna curious,” and businesses from the cannabis world and beyond in what amounted to one giant celebration. The event also featured…

Continue Reading

MondaySep 26, 2022 11:15 am

GeoSolar Technologies Inc. Stands Ready as Green Architecture Seeks to Flip the Script of American Housing

Residential sector is major energy consumer, accounting for more than 20% of US energy consumption; strong push for grid decarbonization coupled with rising energy prices are turning the tide More and more Americans are warming up to idea that their homes could be both energy efficient and comfortable as they seek net-zero homes to control both their carbon footprint and energy bills GeoSolar Technologies is poised to capitalize on this growing market demand with its technology that seeks to revolutionize how homeowners generate and use power As the climate crisis unfolds, it's becoming increasingly clear that residential stock may lie…

Continue Reading

MondaySep 26, 2022 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Receives Letter of Intent for Up to $100 Million Investment from Strategic Investor; Lidar Technology’s Total Addressable Market Projected to Expand Exponentially

Cepton received a letter of intent from Koito for an investment of up to $100 million to help fund Cepton’s next stage of growth as it scales for mass market deployment Lidar technology within urban settings is becoming increasingly ubiquitous across automotive (i.e., assisted driving & autonomous vehicles) and smart infrastructure Since being the recipient of the largest known ADAS contract from an automotive manufacturer within the lidar space, Cepton maintains a major frontrunner Cepton’s (NASDAQ: CPTN) long-term automotive Tier 1 partner, Koito Manufacturing Co., Ltd. recently revealed that it had provided Cepton with a Letter of Intent representing an…

Continue Reading

MondaySep 26, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Reports Added Evidence of Proposed Concussion Therapy’s Safety at High Doses

Medical product developer Odyssey Health Inc. is dedicated to creating solutions for a variety of life-quality situations, such as early detection of heart disease, saving choking victims and treating nervous system ailments Odyssey Health’s primary focus has been advancing its combined device and drug solution for brain concussion injuries through the clinical test process to commercial fulfillment The therapeutic solution, currently known as PRV-002, is designed to deliver a synthetic neurosteroid to injured brain tissue, where it can reduce swelling and sustain needed blood flow The company’s human testing has demonstrated safety with “no serious adverse events,” and Odyssey is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered